Figure 2

ROC curves for receptors for 12 immunomarkers, pathological T category, pathological N category, cell differentiation, tumour length, and the SVM-based models using (A) the training cohort (n=319), (B) the validation cohort (n=164), (C) the mixed training cohort (n=322), and (D) the mixed validation cohort (n=161).